Learn More
Description
Includes
RNA polymerase(s); pGEM™ Express Positive Control Template; RQ1 RNase-free DNase; Recombinant RNasin™ Ribonuclease Inhibitor; rATP; rCTP; rGTP; rUTP; DTT; Transcription-optimized buffer, 5X; Nuclease-free water
- Produce High-Specific-Activity RNA Probes or Defined RNA Transcripts
- Systems available with SP6 RNA Polymerase, T7 RNA Polymerase or T3 RNA Polymerase
- SP6, T7 and T3 RNA Polymerases are extremely promoter-specific, allowing production of virtually homogeneous RNA using plasmid DNA as a template
- Allow synthesis of RNA corresponding to the coding or noncoding strand of cloned DNA from a single plasmid construct
- U.S. Patent 5,552,302; Australian Patent 646803 and other patents.
- Australian Patents 616881 and 641261 and other pending and issued patents, which claim vectors encoding a portion of human placental ribonuclease inhibitor, are exclusively licensed to Promega Corporation.
Specifications
Specifications
| Content And Storage | Store at -20°C. |
| For Use With (Application) | Generation of high-specific-activity RNA probes, generation of microgram quantities of RNA transcripts, generation of RNA processing substrates, generation of antisense RNA |
| Includes | 500U RNA Polymerase (T7), 5μg pGEM™ express positive control template, 500μL transcription optimized 5X Buffer, 2500U recombinant RNasin™ RNase inhibitor, 100mM 100 |
| Product Type | Riboprobe System—T7 |
| Quantity | 1 System |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.